No Data
No Data
Mind Medicine Says New Patent Secured for Investigational Anxiety Disorder Treatment MM120
Mind Medicine (MNMD) said Wednesday that the US Patent and Trademark Office has issued a new patent covering MM120, which is in clinical development for treating generalized anxiety disorder and
Express News | MindMed Announces PAtent Covering MM120 Orally Disintegrating Tablet
Express News | MindMed Announces Issuance of New Patent for Mm120 Orally Disintegrating Tablet (Odt)
Express News | Mind Medicine (MindMed) Inc - “at the Market Offering” Sales Agreement Prospectus Supplement Covering Offering of up to $150 Mln of Common Shares
Express News | Mind Medicine (MindMed) Inc Files for Mixed Shelf-SEC Filing
Express News | MindMed To Be Included In Russell 2000 And Russell 3000 Indexes, Effective Today